Financials
- Market Capitalization 647.72 M
- Employee 191
- Founded 2006
- CEO N/A
- Website www.cormedix.com
- Headquarter Delaware, United States
- FIGI BBG000Q4BQK0
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
5.7
ratio cours/chiffre d'affaires
0
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2747 | PRME Prime Medicine, Inc. - Common Stock | 3.64 USD | +1.68% | +10.98% | +18.57% | +5.20% | 660.21 M USD | ||
| 2751 | MDXG MiMedx Group, Inc - Common Stock | 4.51 USD | +2.04% | +4.88% | +3.44% | -37.19% | 657.38 M USD | ||
| 2774 | SLN Silence Therapeutics Plc - American Depository Share | 13.45 USD | -0.59% | +2.13% | +17.78% | +163.73% | 635.47 M USD | ||
| 2784 | ALT Altimmune, Inc. - Common Stock | 3.24 USD | +2.86% | +8.72% | +8.00% | -12.90% | 630.24 M USD |